Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.
Effect of fampridine on axonal excitability in multiple sclerosis.
Effects of Chronic Scopolamine Treatment on Cognitive Impairments and Myelin Basic Protein Expression in the Mouse Hippocampus.
Specific immune complexes augment in vitro acetylcholine receptor-specific T-cell proliferation.
Pre-operative declining proportion of fractional anisotropy of trigeminal nerve is correlated with the outcome of micro-vascular decompression surgery.
A Hedonism Hub in the Human Brain.
B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responses.
WAC Regulates mTOR Activity by Acting as an Adaptor for the TTT and Pontin/Reptin Complexes.
Optic neuritis and TNF antagonists in IBD.
Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients.
Severe tumefactive rebound of multiple sclerosis following fingolimod cessation.
Overview and diagnosis of multiple sclerosis.
Treatment of active secondary progressive multiple sclerosis with treosulfan.
Aptamer and its applications in neurodegenerative diseases.
Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies.
Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy.
Therapeutic application of monoclonal antibodies in multiple sclerosis.
Geographic population structure in Epstein-Barr Virus revealed by comparative genomics.
Fully automated grey and white matter spinal cord segmentation.
MHC haplotype-dependent regulation of MOG-induced EAE in rats.
A Clinical Decision Support System with an Integrated EMR for Diagnosis of Peripheral Neuropathy.
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
A Sensitive and Automatic White Matter Fiber Tracts Model for Longitudinal Analysis of Diffusion Tensor Images in Multiple Sclerosis.
Gait characteristics according to pyramidal, sensory and cerebellar EDSS subcategories in people with multiple sclerosis.
Neuroinflammatory paradigms in lysosomal storage diseases.
Pages
« first
‹ previous
…
743
744
745
746
747
748
749
750
751
…
next ›
last »